Workflow
Asensus Surgical(ASXC)
icon
Search documents
Asensus Surgical(ASXC) - 2019 Q3 - Earnings Call Transcript
2019-11-13 02:03
TransEnterix, Inc. (TRXC) Q3 2019 Results Earnings Conference Call November 12, 2019 4:30 PM ET Company Participants Mark Klausner - Westwicke Partners Paul LaViolette - Chairman of the Board of Directors Anthony Fernando - President & Chief Executive Officer Joseph Slattery - Executive Vice President & Chief Financial Officer Conference Call Participants Operator Good afternoon, and welcome to the TransEnterix Third Quarter 2019 Corporate Update Conference Call. As a reminder, today's call is being webcast ...
Asensus Surgical(ASXC) - 2019 Q3 - Quarterly Report
2019-11-12 21:51
Table of Contents Emerging Growth Company ☐ Title of each class Trading symbol Name of each exchange on which registered Common Stock $0.001 par value per share TRXC NYSE American UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________ FORM 10-Q _________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANS ...
Asensus Surgical(ASXC) - 2019 Q2 - Earnings Call Transcript
2019-08-08 02:15
Transenterix, Inc. (TRXC) Q2 2019 Earnings Conference Call August 7, 2019 4:30 PM ET Company Participants Mark Klausner - Westwicke Partners Todd Pope - CEO, President & Director Joseph Slattery - EVP & CFO Conference Call Participants Frederick Wise - Stifel, Nicolaus & Company Jeffrey Cohen - Ladenburg Thalmann & Co. Lawrence Keusch - Raymond James & Associates Operator Good afternoon, ladies and gentlemen, and welcome to the TransEnterix Second Quarter 2019 Financial and Operating Results Conference Call ...
Asensus Surgical(ASXC) - 2019 Q1 - Earnings Call Transcript
2019-05-10 01:23
TransEnterix, Inc. (TRXC) Q1 2019 Results Conference Call May 9, 2019 4:30 PM ET Company Participants Mark Klausner - Investor Relations Todd Pope - President and Chief Executive Officer Joe Slattery - Executive Vice President and Chief Financial Officer Conference Call Participants Rick Wise - Stifel Jeffrey Cohen - Ladenburg Larry Keusch - Raymond James Operator Good afternoon, ladies and gentlemen. And welcome to the TransEnterix First Quarter 2019 Financial and Operating Results Conference Call. As a r ...
Asensus Surgical(ASXC) - 2019 Q1 - Quarterly Report
2019-05-09 21:02
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |---------------------------------------------------------------------------|-------|---------------|------- ...
Asensus Surgical(ASXC) - 2018 Q4 - Annual Report
2019-02-27 21:27
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 0-19437 TRANSENTERIX, INC. (Exact name of registrant as specified in its charter) Delaware 11-2962080 (State or other jurisdiction of incorporation ...
Asensus Surgical(ASXC) - 2018 Q4 - Earnings Call Transcript
2019-02-26 19:50
TransEnterix, Inc. (TRXC) Q4 2018 Earnings Conference Call February 26, 2019 8:00 AM ET Company Participants Mark Klausner - Investor Relations Todd Pope - President and Chief Executive Officer Joe Slattery - Executive Vice President and Chief Financial Officer Conference Call Participants Rick Wise - Stifel Glenn Novarro - RBC Capital Markets Larry Keusch - Raymond James Operator Good afternoon, ladies and gentlemen. Welcome to the TransEnterix Fourth Quarter and Full Year 2018 Financial and Operating Res ...